Skin Diseases Treatment Industry Data Book - Acne, Actinic Keratosis, Atopic Dermatitis, Alopecia Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030
- Published Date: Feb, 2023
- Report ID: sector-report-00143
- Format: Electronic (PDF)
- Number of Pages: 300
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation
- 1.1.1 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 GVR’s Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.6.1.1 Approach 1: Commodity Flow Approach
- 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
- 1.7 Global Market: CAGR Calculation
- 1.8 Research Assumptions
- 1.9 List of Secondary Sources
- 1.10 List of Primary Sources
- 1.11 Objectives
- 1.11.1 Objective 1
- 1.11.2 Objective 2
- 1.12 List Of Abbreviations
Chapter 2 Market Definitions
- 2.1 Definitions
Chapter 3 Executive Summary
- 3.1 Market Summary
Chapter 4 Global Skin Diseases Treatment Industry Variables, Trends, & Scope
- 4.1 Skin Diseases Treatment Market Lineage Outlook
- 4.1.1 Parent Market Outlook
- 4.2 Penetration And Growth Prospect Mapping
- 4.3 Regulatory Framework
- 4.4 Market Driver Analysis
- 4.4.1 Increasing prevalence of target diseases such as acne, psoriasis and alopecia
- 4.4.2 Rising awareness regarding dermatology diseases drugs
- 4.4.3 Increasing geriatric population
- 4.4.4 Strong pipeline products and increased R&D investments
- 4.5 Market Restraint Analysis
- 4.5.1 Side effects of dermatology diseases drugs
- 4.5.2 Stringent regulatory framework
- 4.6 Value Chain Analysis
- 4.6.1 Value Chain Analysis/Route To Market
- 4.7 Consumer Behavior Analysis
- 4.8 Major Deals and Strategic Alliances Analysis
- 4.8.1 New product launch
- 4.8.2 Mergers and acquisitions
- 4.8.3 Expansion
- 4.8.4 Partnerships
- 4.8.5 Marketing & promotions
- 4.8.6 Market entry strategies
- 4.9 Skin Diseases Treatment Market Analysis Tools
- 4.9.1 Industry Analysis - Porter’s
- 4.9.2 SWOT Analysis, By Pest
Chapter 5 Skin Diseases Treatment Market - Segment Analysis, by Indication, 2018 - 2030 (USD Million)
- 5.1 Skin Diseases Treatment Market: Indication Analysis
- 5.2 Actinic Keratosis
- 5.2.1 Actinic Keratosis Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 5.3 Atopic Dermatitis
- 5.3.1 Atopic Dermatitis Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 5.4 Alopecia
- 5.4.1 Alopecia Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 5.5 Acne
- 5.5.1 Acne Market Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 6 Skin Diseases Treatment Market - Segment Analysis, by End Use, 2018 - 2030 (USD Million)
- 6.1 Skin Diseases Treatment Market: End Use Analysis
- 6.2 Hospitals
- 6.2.1 Hospitals Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 6.3 Dermatology Clinics
- 6.3.1 Dermatology Clinics Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 6.4 Home Care
- 6.4.1 Home Care Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 6.5 Others
- 6.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7 Skin Diseases Treatment Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)
- 7.1 Skin Diseases Treatment Market: Type Movement Analysis
- 7.2 Prescription
- 7.2.1 Prescription Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.3 OTC
- 7.3.1 OTC Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 8 Skin Diseases Treatment Market - Segment Analysis, by Route of Administration, 2018 - 2030 (USD Million)
- 8.1 Skin Diseases Treatment Market: Route of Administration Movement Analysis
- 8.2 Topical
- 8.2.1 Topical Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.3 Injectable
- 8.3.1 Injectable Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.4 Oral
- 8.4.1 Oral Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 9 Actinic Keratosis Treatment Market - Segment Analysis, by Therapy, 2018 - 2030 (USD Million)
- 9.1 Actinic Keratosis Market: Therapy Movement Analysis
- 9.2 Topical
- 9.2.1 Topical Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.3 Photodynamic Therapy
- 9.3.1 Photodynamic Therapy Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.4 Surgery
- 9.4.1 Surgery Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 10 Actinic Keratosis Treatment Market - Segment Analysis, by Drug Class, 2018 - 2030 (USD Million)
- 10.1 Actinic Keratosis Market: Drug Class Movement Analysis
- 10.2 Nucleoside Metabolic Inhibitor
- 10.2.1 Nucleoside Metabolic Inhibitor Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.3 NSAIDs
- 10.3.1 NSAIDs Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.4 Immune Response Modifiers
- 10.4.1 Immune Response Modifiers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.5 Photo Enhancers
- 10.5.1 Photo Enhancers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 10.6 Others
- 10.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 11 Actinic Keratosis Treatment Market - Segment Analysis, by Drug Type, 2018 - 2030 (USD Million)
- 11.1 Actinic Keratosis Market: Drug Type Movement Analysis
- 11.2 Fluorouracil
- 11.2.1 Fluorouracil Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 11.3 Imiquimod
- 11.3.1 Imiquimod Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 11.4 Diclofenac
- 11.4.1 Diclofenac Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 11.5 Others
- 11.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 12 Alopecia Market - Segment Analysis, by Disease Type, 2018 - 2030 (USD Million)
- 12.1 Alopecia Market: Disease Type Movement Analysis
- 12.2 Alopecia Areata
- 12.2.1 Alopecia Areata Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 12.3 Cicatricial Alopecia
- 12.3.1 Cicatricial Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 12.4 Traction Alopecia
- 12.4.1 Traction Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 12.5 Alopecia Totalis
- 12.5.1 Alopecia Totalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 12.6 Alopecia Universalis
- 12.6.1 Alopecia Universalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 12.7 Androgenetic Alopecia
- 12.7.1 Androgenetic Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 12.8 Others
- 12.8.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 13 Alopecia Market - Segment Analysis, by Treatment, 2018 - 2030 (USD Million)
- 13.1 Alopecia Market: Treatment Movement Analysis
- 13.2 Pharmaceuticals
- 13.2.1 Pharmaceuticals Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 13.3 Devices
- 13.3.1 Devices Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 14 Alopecia Market - Segment Analysis, by Gender, 2018 - 2030 (USD Million)
- 14.1 Alopecia Market: Gender Movement Analysis
- 14.2 Male
- 14.2.1 Male Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 14.3 Female
- 14.3.1 Female Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 15 Atopic Dermatitis Market - Segment Analysis, by Drug Class, 2018 - 2030 (USD Million)
- 15.1 Atopic Dermatitis Market: Drug Class Movement Analysis
- 15.2 Corticosteroids
- 15.2.1 Corticosteroids Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 15.3 Calcineurin Inhibitors
- 15.3.1 Calcineurin Inhibitors Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 15.3.2 Tacrolimus
- 15.3.3 Tacrolimus Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 15.3.4 Pimecrolimus
- 15.3.4 Pimecrolimus Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 15.4 PDE-4 Inhibitors
- 15.4.1 PDE-4 Inhibitors Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 15.5 Biologics
- 15.5.1 Biologics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 15.6 Others
- 15.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 16 Atopic Dermatitis Market - Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)
- 16.1 Atopic Dermatitis Market: Distribution Channel Movement Analysis
- 16.2 Hospital Pharmacies
- 16.2.1 Hospital Pharmacies Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 16.3 Retail Pharmacies
- 16.3.1 Retail Pharmacies Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 16.4 Online Pharmacies
- 16.4.1 Online Pharmacies Market Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 17 Acne Drugs Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
- 17.1 Acne Drugs Market: Product Movement Analysis
- 17.2 Retinoids
- 17.2.1 Retinoids Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 17.3 Antibiotics
- 17.3.1 Antibiotics Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 17.4 Isotretinoin
- 17.4.1 Isotretinoin Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 17.5 Others
- 17.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 18 Acne Drugs Market - Segment Analysis, by Age Group, 2018 - 2030 (USD Million)
- 18.1 Acne Drugs Market: Age Group Movement Analysis
- 18.2 9-20 years
- 18.2.1 9-20 years Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 18.3 21-40
- 18.3.1 21-40 years Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 18.4 Over 41years
- 18.4.1 Over 41 years Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 19 Acne Drugs Market - Segment Analysis, by Distribution Channel, 2018 - 2030 (USD Million)
- 19.1 Acne Drugs Market: Distribution Channel Movement Analysis
- 19.2 Hospital Pharmacies
- 19.2.1 Hospital Pharmacies Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 19.3 Retail Pharmacies
- 19.3.1 Retail Pharmacies Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 19.4 Online Pharmacies
- 19.4.1 Online Pharmacies Market Estimates and Forecast, 2018 - 2030 (USD Million)
Chapter 20 Skin Diseases Treatment Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)
- 20.1 Skin Diseases Treatment Market: Regional Movement Analysis
- 20.2 North America
- 20.2.1 North America, SWOT Analysis
- 20.2.2 North America Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.2.3 U.S.
- 20.2.3.1 U.S. Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.2.4 Canada
- 20.2.4.1 Canada Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.3 Europe
- 20.3.1 Europe, SWOT Analysis
- 20.3.2 Europe Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.3.3 U.K.
- 20.3.3..1 U.K. Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.3.4 Germany
- 20.3.4.1 Germany Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.3.5 Spain
- 20.3.5.1 Spain Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.3.6 France
- 20.3.6.1 France Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.3.9 Italy
- 20.3.20.1 Italy Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.3.8 Denmark
- 20.3.8.1 Denmark Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.3.9 Sweden
- 20.3.9.1 Sweden Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.3.10 Norway
- 20.3.10.1 Norway Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.4 Asia Pacific
- 20.4.1 Asia Pacific, SWOT Analysis
- 20.4.2 Asia Pacific Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.4.3 Japan
- 20.4.3.1 Japan Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.4.4 China
- 20.4.4.1 China Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.4.5 India
- 20.4.5.1 India Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.4.6 South Korea
- 20.4.6.1 South Korea Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.4.9 Thailand
- 20.4.20.1 Thailand Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.4.8 Australia
- 20.4.8.1 Australia Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.5 Latin America
- 20.5.1 Latin America, SWOT Analysis
- 20.5.2 Latin America Market Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.5.3 Brazil
- 20.5.3.1 Brazil Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.5.4 Mexico
- 20.5.4.1 Mexico Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.5.5 Argentina
- 20.5.5.1 Argentina Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.6 Middle East and Africa
- 20.6.1 Middle East & Africa, SWOT Analysis
- 20.6.2 Middle-East And Africa Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.6.3 South Africa
- 20.6.3.1 South Africa Market Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.6.4 United Arab Emirates
- 20.6.4.1 United Arab Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.6.5 Saudi Arabia
- 20.6.5.1 Saudi Arabia Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 20.6.6 Kuwait
- 20.6.6.1 Kuwait Skin Diseases Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 21 Competitive Analysis
- 21.1 Recent Developments & Impact Analysis, By Key Market Participants
- 21.1.1 Handoff Matrix
- 21.1.2 Company/Competition Categorization (Key Innovators, Market Leaders, Expansion)
- 21.1.3 Innovators
- 21.2 Vendor Landscape
- 21.2.1 List Of Key Distributors And Channel Partners
- 21.2.2 Global Skin Diseases Treatment Market: Key Company Market Share Analysis, 2022
- 21.3 Public Companies
- 21.3.1 Company Market Position Analysis
- 21.3.2 Competitive Dashboard Analysis
- 21.3.3 Strategic Framework
- 21.4 Private Companies
- 21.4.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
- 21.4.2 Regional Network Map
- 21.5 Company Profiles
- 21.5.1 Novartis AG
- 21.5.1.1 Company Overview
- 21.5.1.2 Alere, Inc.
- 21.5.1.3 Financial Performance
- 21.5.1.4 Product Benchmarking
- 21.5.1.5 Strategic Initiatives
- 21.5.2 AbbVie, Inc.
- 21.5.2.1 Company Overview
- 21.5.2.2 Financial Performance
- 21.5.2.3 Product Benchmarking
- 21.5.2.4 Strategic Initiatives
- 21.5.3 Amgen Inc.
- 21.5.3.1 Company Overview
- 21.5.3.2 Financial Performance
- 21.5.3.3 Product Benchmarking
- 21.5.3.4 Strategic Initiatives
- 21.5.4 Johnson & Johnson Services Inc.
- 21.5.4.1 Company Overview
- 21.5.4.2 Financial Performance
- 21.5.4.3 Product Benchmarking
- 21.5.4.4 Strategic Initiatives
- 21.5.5 Leo Pharma A/S.
- 21.5.5.1 Company Overview
- 21.5.5.2 Financial Performance
- 21.5.5.3 Product Benchmarking
- 21.5.5.4 Strategic Initiatives
- 21.5.6. Sun Pharmaceutical Industries Ltd.
- 21.5.6.1 Company Overview
- 21.5.6.2 Financial Performance
- 21.5.6.3 Product Benchmarking
- 21.5.6.4 Strategic Initiatives
- 21.5.7 Eli Lilly and Company
- 21.5.7.1 Company Overview
- 21.5.7.2 Financial Performance
- 21.5.7.3 Product Benchmarking
- 21.5.7.4 Strategic Initiatives
- 21.5.8 GSK plc
- 21.5.21.1 Company Overview
- 21.5.21.2 Financial Performance
- 21.5.21.3 Product Benchmarking
- 21.5.21.4 Strategic Initiatives
- 21.5.9 AstraZeneca
- 21.5.9.1 Company Overview
- 21.5.9.2 Financial Performance
- 21.5.9.3 Product Benchmarking
- 21.5.9.4 Strategic Initiatives
- 21.5.10 Teva Pharmaceutical Industries Ltd.
- 21.5.10.1 Company Overview
- 21.5.10.2 Financial Performance
- 21.5.10.3 Product Benchmarking
- 21.5.10.4 Strategic Initiatives
- 21.5.11 Pfizer Inc
- 21.5.11.1 Company Overview
- 21.5.11.2 Financial Performance
- 21.5.11.3 Product Benchmarking
- 21.5.11.4 Strategic Initiatives
- 21.5.12 UCB S.A.
- 21.5.12.1 Company Overview
- 21.5.12.2 Financial Performance
- 21.5.12.3 Product Benchmarking
- 21.5.12.4 Strategic Initiatives
- 21.5.13 GALDERMA
- 21.5.13.1 Company Overview
- 21.5.13.2 Financial Performance
- 21.5.13.3 Product Benchmarking
- 21.5.13.4 Strategic Initiatives
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.